Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms ( ...

In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...

Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

April 15, 2025—enVVeno Medical Corporation recently announced the presentation of findings from a subanalysis of the 1-year data from the prospe ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, annou ...

Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

Microbot Medical Inc., a precommercial-stage medical technology company that is developing the Liberty endovascular robotic system ...

Brainomix announced the FDA clearance of a feature that enables physicians to assess ischemic core volume from universally ...

Cagent Vascular, Inc. announced that the first patient was enrolled in the Serranator OCT study. The study will use intravascular ...